Back
Return
Biography
Öner

Dr. Öner Özdemir

Sakarya University, Turkey

Professor


E-mail: ozdemir_oner@hotmail.com; oner.ozdemir.md@gmail.com


Qualifications

10/2013- Current   Head and Professor, Sakarya University, Turkey

10/2010-10/2013    Chief and Associate Professor, Istanbul Medeniyet University, Turkey

10/2007-10/2010    Associate Professor, Turkish Institution of Higher Education, Turkey

05/2006–10/2006  Clinical fellow, University of Cincinnati College of Medicine, USA

08/2004–05/2006   Clinical fellow, Louisiana State University Health Sciences Ctr., USA


Publications (Selected)

Books

  1. Ozdemir O. Mast cells and the tumor-associated neoangiogenesis. Med Sci Monit. 2006; 12(6): LE9-11.
  2. Ozdemir O. Idiopathic (Autoimmune) Chronic Urticaria - Pearls and Pitfalls. Allergy and Asthma Proceedings. 2006; 27(5): 431-4.
  3. Ozdemir O. Flow Cytometric Cell-Mediated Cytotoxicity Assay. J Immunol Methods 2006; 318: 158-9.
  4. Ozdemir O. Evaluation of human mast cell-mediated cytotoxicity by DIOC18 target cell labeling in flow cytometry. Journal of Immunological Methods. 2007; 319: 98–103.
  5. Ozdemir O. Human mast cell-mediated cytotoxicity against human tumor cells and mechanisms. Türkiye Klinikleri Tıp Bilimleri Dergisi [Turkiye Klinikleri J Med Sci], 2007; 27, 99-106.
  6. Ozdemir O, Mete E. Natural rubber latex allergy–pearls and pitfalls. Türkiye Klinikleri Tıp Bilimleri Dergisi [Turkiye Klinikleri J Med Sci], 2007; 27: 394-397.
  7. Göksu AY, Ozdemir O. Increasing importance of mast cells in microbiology and newly defined roles. Türkiye Klinikleri Tıp Bilimleri Dergisi [Turkiye Klinikleri J Med Sci], 2007; 27: 577-588.
  8. Ozdemir O, Mete E, Catal F, Ozol D. Food Intolerances and Eosinophilic Esophagitis in Childhood. Dig Dis Sci., 2009; 54: 8–14.
  9. Ozdemir O. Food protein induced proctocolitis in neonatal and infantile period: Clinical, endoscopic, hystopathologic findings and therapy. Turk Arch Ped., 2009; 44: 152-4.
  10. Ozdemir O. Food- Protein Induced Enterocolitis. Türkiye Klinikleri Tıp Bilimleri Dergisi [Turkiye Klinikleri J Med Sci], 2009; 29: 1705-9.
  11. Göksu AY, Ozdemir O. The Association of Mast Cell Density with Myometrial Invasion in Endometrial Carcinoma. A Preliminary Report. Pathol Res Pract, 2010; [Epub ahead of print].
  12. Ozdemir O. Any Benefits of Probiotics in Allergic Disorders. Allergy Asthma Proc 2010; 31: 103-11.
  13. Ozdemir O. Various Effects of Different Probiotic Strains in Allergic Disorders: an Update from Laboratory and Clinical Data. Clinical and Experimental Immunology. 2010 Mar 16. [Epub ahead of print].
  14. Ozdemir O. Development of antiepileptic hypersensitivity syndrome after phenytoin treatment. Turk J Pediatr 52, 111-2 (2010); author reply 113-4.
  15. Göksu-Erol A.Y., Gokcimen A,Özdemir, Ö.“Growth Failure, Hepatic Damage, Tardive Dyskinesia and Megacolon Development in Neonatal Rats Following Exposure to Trimethobenzamide in Utero”. J Matern Fetal Neonatal Med. 2010 Dec 7. PMID: 21133831.
  16. Ozdemir O. Measuring Human Mast Cell-mediated Cytotoxicity against Human Tumor Cells: Three-color Flow Cytometry Using Monoclonal Antibody Target Staining with Annexin V / Propidium Iodide Co-labeling of Death”. Allergol Immunopathol (Madr). 2011 Jan 12. [Epub ahead of print] PMID: 21236549.
  17. Ozdemir O. Flow Cytometric Mast Cell-mediated Cytotoxicity Assay: A New Three-color Flow Cytometric Approach Using Monoclonal Antibody Staining with Annexin V / Propidium Iodide Co-labeling to Assess Human Mast Cell-mediated Cytotoxicity by Fluorosphere-adjusted Counts. ” J Immunol Methods. 2011 Feb 28; 365(1-2): 166-73.
  18. Göksu Erol AY,Özdemir, Ö.“Newly defined roles of mast cells in surgical diseases and cancer (Mast Hücrelerinin Cerrahi Hastalıklar ve Cerrahi Tümörlerdeki Yeni Tanımlanan Rolleri)”. Türkiye Klinikleri Tıp Bilimleri Dergisi [Turkiye Klinikleri J Med Sci], 2011 (31) 4: 969- 975.
  19. Goksu Erol AY, Tokyol C,Özdemir Ö, Yilmazer M, Arioz TD, Aktepe F. VEGF and COX-2 Expression in endometrial carcinoma. Turkiye Klinikleri J Med Sci 2012; 32(1): 80–7.